Skip to content
Connexio Health
  • Home
  • Company
    • About
    • History
    • Careers
  • Solutions
    • Downstream Demand Generation
    • Virtual Clinical Education
    • Data Intelligence
    • Virtual Account Management
  • Resources
    • Articles
    • Case Studies
    • Whitepapers
    • Hidden Growth Quiz
    • FAQs
    • Connexio Pulse Podcasts
  • Contact
  • Round 2028: What’s Included in Medicare’s DMEPOS Competitive Bidding Program

    Round 2028: What’s Included in Medicare’s DMEPOS Competitive Bidding Program

    CMS has finalized the next round of Medicare’s Durable Medical Equipment, Prosthetics, Orthotics, and Supplies Competitive Bidding Program (DMEPOS CBP). Known as Round 2028, it is the broadest expansion of the program to date, covering seven product categories and introducing two entirely new categories for the first time.

    What Is the DMEPOS Competitive Bidding Program?

    The DMEPOS CBP was mandated by Congress through the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Rather than paying a fixed fee schedule, CMS periodically opens a new “round,” suppliers submit bids to furnish specific product categories, and CMS awards a limited number of contracts to the suppliers offering quality items and services at competitive payment rates.

    Round 2028 was finalized at the close of 2025, when CMS issued the CY 2026 Home Health and DMEPOS final rule. It is the first round to include ostomy and urological supplies, which had previously been excluded from the program.

    What’s Included in Round 2028

    CMS has announced the number of contracts it plans to award nationwide in each of the seven product categories that make up Round 2028:

    • Class II Continuous Glucose Monitors and Insulin Pumps: 10 contracts
    • Hydrophilic Urinary Catheters: 10 contracts
    • Off-the-Shelf (OTS) Back Braces: 3 contracts
    • OTS Knee Braces: 4 contracts
    • OTS Upper Extremity Braces: 5 contracts
    • Ostomy Supplies: 6 contracts
    • Urological Supplies: 5 contracts

    Ostomy Supplies and Urological Supplies are the two categories new to competitive bidding under this round. Contracted suppliers ship product to beneficiaries’ homes nationwide, or, where a contracted supplier has a local storefront, beneficiaries can pick items up there.

    The Timeline

    CMS has laid out a multi-year rollout for Round 2028, with target dates that may shift as the program develops:

    • June 4, 2026: CMS begins its pre-bidding supplier awareness program.
    • Summer 2026: CMS announces specific registration and bidding dates, publishes the lead item and number of contracts to be awarded for each product category, and begins its bidder education program.
    • Late Fall 2026: Bidder registration opens for suppliers to obtain user IDs and passwords, and the bid window opens.
    • Late Summer / Early Fall 2027: CMS awards contracts and announces single payment amounts (SPAs); beneficiary education begins.
    • No Later Than January 1, 2028: Round 2028 officially starts, with contracts and single payment amounts in effect. A six-month transition (grace) period also begins, during which contract suppliers can obtain written orders for beneficiaries who were using a non-contracted supplier before the switch.

    Ordering continues as it does today until Round 2028 takes effect. The registration, bidding, and contract-award milestones above apply to suppliers preparing to bid, not to beneficiaries or their current ordering process.


    Source: CMS DMEPOS Competitive Bidding Program, dmeposcompetitivebid.cms.gov. Dates listed are CMS target dates and subject to change.

    Kathryn Kellam

    September 28, 2026
    News, Connexio Health
    CMS, DMEPOS, Healthcare, Round 2028, Sales Strategy
  • Is Your Commercial Team Ready for 2027? Five Questions to Ask Before the Plan Locks

    Is Your Commercial Team Ready for 2027? Five Questions to Ask Before the Plan Locks

    Every fall, healthcare manufacturers review territories, build budgets, and shape the next year’s commercial plan. And every fall, the same growth killers slip through. It isn’t for lack of effort. Most planning processes are built to allocate what exists rather than find what’s missing.

    Readiness is different. Planning asks, “How do we deploy our resources?” Readiness asks, “Are we equipped to win the market in front of us?” The gap between those questions is where growth quietly leaks away. Here are five concepts every med-tech, pharma, and diagnostics commercial leader should pressure-test before the 2027 plan is final.

    1. Your data foundation determines everything downstream

    Effective commercialization starts with integrated, high-quality data, and that means more than a tidy CRM. A smart targeting foundation draws from three layers: your own customer and prospect records, third-party provider-level intelligence (industry standards like Definitive Healthcare and IQVIA, plus newer players like Alpha Sophia bringing innovative approaches to targeting, enrichment, and segmentation), and real-world claims data showing where volume actually lives. If your team can’t answer which accounts represent our best opportunity, and who is covering them? in one meeting, this is the first gap to close.

    2. Whitespace is the norm, not the exception

    Research spanning more than 500 sales forces found that 55% of sales territories are either too large or too small at any given time, and that realigning existing territories alone can increase revenue by 2–7% (Zoltners & Lorimer, Journal of Personal Selling & Sales Management).

    And that’s just misaligned coverage. True whitespace is an even larger unaddressed opportunity: territories no one reaches, products that aren’t a priority in the rep’s bag, and facilities never on the call plan. In our client programs, the pattern is consistent. Accounts without coverage decline, while covered accounts hold and grow. The question isn’t “do we have whitespace?” Almost everyone does. It’s “have we mapped it, valued it, and assigned a coverage model to it?”

    3. Education is a revenue lever, not a cost center

    In healthcare, revenue isn’t realized at the decision. It’s realized at utilization, when clinicians are confident, trained, and actually using the product. In Connexio’s advanced wound care clinical education program, spanning more than 10,000 virtual in-services across 4,700 facilities, accounts saw a 63% increase in sales in the first month following a virtual in-service. If your 2027 plan funds demand generation generously but treats training as an afterthought, it’s optimized for the wrong half of the revenue equation.

    4. Content readiness means selling value, not just features

    A strong content ecosystem arms the sales conversation: economic value propositions, ROI calculators, credible clinical evidence, and patient-facing materials that support adoption after the sale. The audit questions are simple. Does the field have the right tools? Can they sell economic value, not just clinical value? Most organizations haven’t asked them systematically since the last launch.

    5. Channel mix should follow evidence, not habit

    The Pareto Principle holds up in channel audits: roughly 80% of results come from about 20% of the channel mix. The discipline is knowing which 20%. That means auditing digital, direct, live, and content channels by measurable impact, then doubling down instead of spreading budget evenly out of habit.

    The stakes are quantifiable. McKinsey research across more than 60 medtech companies found that those with the most advanced commercial capabilities grew 1.4x faster than peers with average capabilities. Commercial readiness isn’t housekeeping. It’s a growth strategy.

    The timing matters

    An initiative that isn’t in the 2027 budget by Q4 doesn’t happen in 2027, because scoping, data integration, and team build-out all happen before launch. Teams that assess readiness now enter planning season with a fact base. Teams that wait inherit last year’s assumptions.

    Get the full framework

    The complete assessment is in our whitepaper, Winning the Healthcare Market: A Strategic Guide to Sales & Marketing Readiness. It includes the full readiness checklist across data, coverage, education, content, and channels, plus benchmark questions to score your organization.

    Download the whitepaper here.

    Connexio Health builds revenue activation channels for med-tech, pharma, and diagnostics manufacturers, activating the territories, products, and markets your field team can’t reach. Contact us at info@connexiohealth.com or 607-545-4010.

    Kathryn Kellam

    September 1, 2026
    Whitespace, Clinical Education, Connexio Health, IFU, Non-Personal Promotion, VSO
    Clinical Education, Healthcare marketing, Marketing, Sales organization, Sales Strategy
  • The Hidden Growth Channel™ in Healthcare: Where Revenue Is Already Waiting

    The Hidden Growth Channel™ in Healthcare: Where Revenue Is Already Waiting

    Most healthcare manufacturers are built on strong fundamentals: solid products, capable field teams, and established customer relationships. But even when the core business is performing, revenue doesn’t automatically “compound” across the market.

    It stalls in the places teams can’t consistently reach.

    That’s where the Hidden Growth Channel comes in.

    The Hidden Growth Channel is the revenue potential that already exists inside your commercial ecosystem—accounts you’ve touched before, markets that show demand signals, customers who are at risk of drifting, or segments that never receive enough follow-through to convert. It’s not a pipeline problem. It’s an execution capacity problem.

    In healthcare, this shows up in familiar ways:

    • Territories that remain undercovered because field teams must prioritize top accounts
    • High-value accounts that need more touches than reps can sustain
    • Referral networks and community settings that influence demand but sit outside the “core list”
    • Launch and lifecycle moments where the right follow-through is difficult to scale
    • Existing accounts with unrealized cross-sell or expansion potential

    The opportunity is there—but it’s distributed across systems, geographies, and decision-makers. And it changes constantly.

    Why this matters now

    Healthcare manufacturers are operating in an environment where expectations are rising, but execution bandwidth is not.

    Field teams are stretched. Access is complex. Stakeholders are fragmented. And “more campaigns” rarely solve the real issue: consistent follow-through at scale.

    The Hidden Growth Channel reframes the question from:

    • “What should we do next?” to
    • “Where is revenue already embedded in our footprint—and what execution would unlock it?”

    At Connexio Health, we see Hidden Growth as a practical execution problem—not a marketing concept.

    The work starts by uncovering where opportunity exists across your footprint, then extending execution capacity to the decision moments that matter most—without adding permanent headcount or creating noise. And it only works if outcomes are measurable.

    Because in a market as complex as healthcare, growth doesn’t stall from a lack of strategy.

    The next step is simple: identify where revenue is already embedded in your footprint—and determine what execution will unlock it.

    Kathryn Kellam

    March 30, 2026
    Connexio Health, News
  • Whitespace Growth in Healthcare: How to Expand Coverage Without Expanding Headcount

    Whitespace Growth in Healthcare: How to Expand Coverage Without Expanding Headcount

    In healthcare commercialization, growth is often tied to expansion—more territory coverage, more field representatives, and more operational infrastructure. But many organizations reach a point where expanding the team becomes increasingly difficult due to budget constraints, hiring timelines, or operational complexity.

    At the same time, revenue opportunities continue to exist in markets that fall outside the reach of existing field teams.

    This is where whitespace strategy becomes essential.

    A healthcare whitespace strategy focuses on identifying and activating opportunities that exist beyond the core territory footprint. Instead of expanding headcount, organizations can extend their commercial reach through smarter coverage models that increase engagement across underserved markets.

    The result is expanded sales coverage without the operational burden of scaling a traditional field organization.


    What “Whitespace” Actually Means in Pharma and Medical Device

    In pharmaceutical and medical device organizations, whitespace refers to healthcare providers, institutions, or geographic markets that are not actively engaged by the existing sales team.

    These gaps occur for several reasons:

    • Territory sizes exceed what field representatives can realistically cover
    • Lower-volume accounts receive limited or no engagement
    • Newly identified providers fall outside existing targeting models
    • Expansion into new specialties or clinical segments creates uncovered opportunities

    Field teams naturally prioritize high-value accounts within their territories. As a result, entire segments of the market remain largely untouched, even though they represent legitimate revenue potential.

    Whitespace is not just unused territory—it is unrealized commercial capacity within the healthcare market.

    Organizations that identify and activate these opportunities can unlock growth without disrupting their core field strategy.


    Why Territory Maps Hide Revenue

    Traditional territory maps are designed to organize sales teams, not necessarily to maximize market coverage.

    On paper, territories often appear fully covered. In reality, they contain large pockets of under-engagement.

    Several structural factors contribute to this hidden whitespace:

    1. Limited Field Capacity
    A typical field representative can only engage a fraction of the providers within a territory. Travel time, scheduling limitations, and administrative responsibilities restrict the number of meaningful interactions possible each week.

    2. Account Prioritization
    Reps understandably focus on their highest-value accounts. This means smaller or emerging opportunities receive little attention, even if they collectively represent significant revenue.

    3. Expanding Provider Networks
    Healthcare provider databases grow constantly as new practices, specialists, and treatment centers emerge. Territory planning rarely keeps pace with these changes.

    4. Coverage Gaps Between Territories
    Certain markets sit between territories or across organizational boundaries, creating areas where no team is clearly responsible for engagement.

    When organizations evaluate their coverage at the provider level rather than the territory level, they often discover that large portions of the addressable market remain untouched.


    Cost Comparison: FTE vs. Continuous Execution

    The most common response to coverage gaps is to hire additional field representatives. While effective in some cases, expanding the field team is one of the most expensive and time-consuming ways to increase coverage.

    A typical healthcare field representative carries substantial total cost once salary, benefits, travel, management overhead, and onboarding are included.

    Beyond cost, organizations must also consider:

    • Recruitment timelines
    • Territory realignment complexity
    • Ramp-up periods before productivity begins
    • Long-term headcount commitments

    For many organizations, these constraints make hiring impractical for addressing smaller or fragmented whitespace markets.

    An alternative approach is continuous execution models, which extend coverage across underserved accounts without requiring permanent headcount expansion.

    Instead of assigning a dedicated representative to a fixed territory, organizations deploy structured engagement programs that systematically reach providers outside the core field footprint.

    This allows companies to expand sales coverage without hiring additional full-time staff while maintaining operational flexibility.


    The Operational Model Behind Expanded Coverage

    Expanding coverage without adding headcount requires a structured execution model designed specifically for whitespace markets.

    These models typically include several operational components:

    Target Identification

    The first step is identifying the providers or accounts that fall outside current engagement patterns.

    This requires combining multiple datasets—including prescribing data, provider affiliations, and market activity—to pinpoint where engagement is missing but opportunity exists.

    Advanced segmentation can also identify emerging specialists or previously overlooked practices.

    Structured Outreach Programs

    Once targets are identified, organizations deploy engagement programs designed to reach these providers through scalable touchpoints.

    This can include:

    • Virtual clinical engagement
    • targeted education programs
    • digital outreach
    • remote account management

    These programs provide consistent engagement without requiring the travel and scheduling constraints of traditional field activity.

    Alignment With Field Sales

    Whitespace programs work best when they complement—not compete with—the existing field team.

    High-value opportunities identified through expanded coverage can be transitioned back to field representatives for deeper relationship development.

    This approach ensures that expanded coverage supports the field rather than replacing it.

    Continuous Market Monitoring

    Whitespace opportunities evolve as markets change. A successful model continuously evaluates engagement data and adjusts targeting to maintain efficient coverage.

    The goal is not simply to fill gaps once, but to create an ongoing channel for commercial execution beyond the core field footprint.


    Metrics That Matter

    Organizations evaluating whitespace strategies should focus on metrics that reflect true coverage expansion rather than simple activity volume.

    Key performance indicators include:

    Market Coverage Rate
    The percentage of addressable providers actively engaged within a given timeframe.

    Reach and Frequency
    How many unique providers are engaged and how consistently they are contacted.

    Opportunity Identification
    New accounts, prescribing activity, or referral patterns discovered through expanded engagement.

    Cost of Coverage
    The cost required to reach each additional provider compared to traditional field engagement.

    Revenue Contribution
    Incremental sales or prescribing activity generated from previously unengaged accounts.

    When tracked consistently, these metrics provide a clear view of whether a whitespace strategy is successfully expanding commercial reach.


    Turning Whitespace Into Growth

    Healthcare markets are rarely fully covered, even when territory maps suggest otherwise. Beneath those maps are thousands of providers and institutions that receive little or no engagement.

    Organizations that recognize this gap can unlock growth by expanding coverage through structured execution models rather than traditional headcount expansion.

    By identifying underserved accounts, deploying scalable engagement programs, and aligning these efforts with field teams, healthcare companies can activate previously unreachable parts of the market.

    Whitespace is not simply unused territory—it is an opportunity to extend commercial reach and capture growth that would otherwise remain hidden.

    Kathryn Kellam

    March 4, 2026
    Marketing, Connexio Health, Healthcare Manufacturing, Non-Personal Promotion, VSO, Whitespace
  • A Smarter Way to Scale in the New Year: Rethinking Sales and Marketing in Healthcare 

    A Smarter Way to Scale in the New Year: Rethinking Sales and Marketing in Healthcare 

    January brings renewed energy—and renewed pressure. New budgets are approved, goals are set, and leadership teams feel the urgency to move quickly. For many healthcare organizations, that urgency translates into a familiar response: hire more people, build larger teams, and scale fast. 

    But speed doesn’t always come from size. And growth doesn’t always require permanent headcount. 

    More healthcare organizations are starting the year with a different mindset—one focused on flexibility, focus, and right-sized execution. 

    The Pressure to Build Fast in January 

    The start of the year often feels like a race against the calendar. Commercial teams are expected to show momentum early, validate investments quickly, and demonstrate progress before Q2 even begins. 

    In that environment, traditional sales and marketing models can create friction: 

    1. Long hiring timelines delay execution 
    2. Fixed costs are committed before strategies are fully validated 
    3. Teams are built for scale before focus is established 

    The result is often overextension—resources deployed broadly, but not always effectively. 

    The Evolving Role of Traditional Commercial Models

    Healthcare markets are complex, highly regulated, and rarely predictable. Yet many commercial models are designed as if growth will follow a straight line. 

    Common challenges include: 

    1. Inflexibility: Once teams are built, it’s difficult to adjust quickly 
    2. Misalignment: Sales and marketing resources may outpace strategy 
    3. Risk concentration: Significant investment is made before outcomes are clear 

    When execution begins before clarity is established, even well-funded initiatives can stall. 

    The Rise of Fractional Sales and Marketing in Healthcare 

    Fractional sales and marketing models have gained traction not because they are cheaper—but because they are smarter. 

    At their core, fractional partnerships offer healthcare organizations: 

    1. Access to experienced commercial talent without long ramp times 
    2. The ability to scale support up or down as needs evolve 
    3. Faster execution with lower upfront risk 

    Rather than committing to a fixed structure, organizations can build commercial support that adapts alongside the business. 

    Choosing the Right Model for the Moment 

    Not every organization needs the same level of support at the same time. The most effective commercial strategies align structure to stage. 

    That may include: 

    1. Full-scale sales and marketing programs for organizations ready to expand coverage and accelerate growth 
    2. Project-based engagements to support launches, pilots, or targeted initiatives 
    3. Flexible 1099 teams that expand reach without long-term commitments 

    Each approach serves a different purpose. The key is matching the model to the opportunity in front of you—not defaulting to scale too early. 

    Start with Clarity Before Scale 

    Before adding resources, one foundational question must be answered: 

    Who are you really trying to reach? 

    Clear Ideal Customer Profiles (ICPs) create focus across sales and marketing by: 

    1. Aligning messaging and engagement 
    2. Prioritizing the right accounts and segments 
    3. Reducing wasted effort and misdirected spend 

    Without this clarity, even the most robust teams struggle to generate meaningful results. Strategy must lead execution—not the other way around. 

    Build Smarter This Year 

    The start of the year is a natural moment to reassess—not just goals, but how those goals will be achieved. 

    For many healthcare organizations, the smartest path forward isn’t about building bigger teams. It’s about building the right model—one that supports momentum today and adapts as the business evolves. 

    Growth doesn’t have to be all or nothing.  And January doesn’t have to be about overcommitting. 

    Sometimes, the strongest move is choosing flexibility first. 

    Connexio Health

    January 16, 2026
    Connexio Health, Non-Personal Promotion
  • Beyond Optimization: Building Healthcare Systems That Can Adapt

    Beyond Optimization: Building Healthcare Systems That Can Adapt

    Optimization has become the buzzword of modern healthcare. Every system, every workflow, every message is measured, streamlined, and refined in pursuit of greater efficiency.

    But what happens when everything is optimized for a world that no longer exists?

    The truth is, healthcare’s greatest challenge isn’t inefficiency—it’s inflexibility. And in an environment defined by change, adaptability has become the new gold standard.

    The Optimization Trap

    Optimization sounds like progress. But too often, it hardens systems instead of strengthening them.

    We build for precision—then struggle to pivot. We design for cost control—then can’t respond to disruption. We implement technology to improve performance—but only for the scenarios we already know.

    Optimization is valuable when the world is predictable. Healthcare isn’t.

    The lesson of the past few years is clear: success doesn’t belong to the organizations that move fastest, but to those that can move differently.

    Adaptability as a Strategic Advantage

    In healthcare, adaptability means more than reacting—it means building systems designed to evolve.

    An adaptable organization can:

    1. Shift commercial models as markets change.
    2. Reconfigure teams and technologies without starting over.
    3. Turn new data into immediate insight instead of delayed analysis.


    This requires a mindset change: from maximizing what is to anticipating what could be. It’s not about doing more with less—it’s about doing the right things with intent and flexibility.

    At Connexio Health, we see this every day. The programs that thrive aren’t the ones that run perfectly on paper. They’re the ones that can reframe, realign, and respond.

    Resilience Over Perfection

    Resilience doesn’t come from optimization—it comes from preparedness.

    It’s built through systems that bend without breaking, strategies that evolve with data, and teams empowered to make decisions as realities shift.

    In this sense, adaptability is both an operational and a cultural asset. It’s how organizations weather uncertainty and continue to deliver value when markets fluctuate, patient needs shift, or technology transforms overnight.

    Optimization can create short-term wins. Adaptability ensures long-term relevance.

    The Next Era of Healthcare Transformation

    The future of healthcare won’t be defined by who is most efficient, but by who is most prepared for change.

    It’s time to move beyond optimization—to build frameworks that can flex, scale, and grow in ways that mirror the complexity of modern healthcare itself.

    Because in an unpredictable world, perfection is temporary.

    But adaptability endures.

    Connexio Health

    November 20, 2025
    Connexio Health, Data and Technology, Healthcare Manufacturing, Marketing, News
  • How Content Fatigue Is Eroding Sales & Marketing Impact in Healthcare

    How Content Fatigue Is Eroding Sales & Marketing Impact in Healthcare

    In today’s high-stakes healthcare marketing environment, organizations are producing more content than ever—blogs, social posts, videos, whitepapers, webinars, and more. Yet despite this surge in output, many are seeing diminishing returns. The reason: content fatigue. And in healthcare, its impact extends across both marketing and sales.

    What Is Content Fatigue—and Why It Matters

    Content fatigue occurs when audiences are exposed to large volumes of information and begin to disengage or ignore it. As one analysis describes it, people feel overwhelmed, tired, and ultimately tune out much of the social, email, video, and blog content presented to them.

    In healthcare, the effect is intensified by:

    • The high trust placed in health information (audiences expect accuracy and relevance).
    • Compliance and regulatory constraints can slow production and limit flexibility.
    • Time-pressed, risk-averse audiences—clinicians, patients, and payers—who filter aggressively for what matters.

    How Content Fatigue Is Impacting Healthcare Marketing and Sales

    1. Declining Engagement and Conversion

    Engagement metrics across healthcare continue to fall. For example, paid search click-through rates have dropped more than 50% year-over-year, the steepest decline across all industries in the dataset. When audiences disengage, top-of-funnel activity weakens—fewer leads, slower movement, and softer brand connection.

    2. The Relevance vs. Reach Trade-Off

    Casting a wide net often leads to generic content that fails to resonate. Some argue that what appears to be content fatigue is actually content irrelevance. In healthcare, broad “wellness tips” or catch-all messaging rarely perform as well as highly targeted content built for a specific clinical role, specialty, or condition.

    3. Erosion of Brand Trust

    Healthcare is fundamentally trust-driven. When content feels repetitive, superficial, or misaligned with audience needs, it can erode credibility. Healthcare audiences expect accuracy, depth, and tailored communication.

    4. Inefficient Use of Resources

    Teams often feel pressure to produce more content, faster—without tightening strategy or refining targeting. As audiences tune out, content ROI falls, creating a cycle of more activity with less impact.

    5. Sales Friction and Lost Opportunities

    When marketing content fails to engage, the entire sales funnel is affected: fewer qualified leads, slower nurture cycles, and weaker pipelines. Healthcare organizations risk losing providers, patients, or payers to competitors with more compelling and differentiated messaging.

    Why Healthcare Is Especially Vulnerable

    • High noise levels: Providers and patients are inundated with treatment updates, device promotions, webinars, and wellness communication.
    • Regulatory barriers: FDA, HIPAA, and compliance teams can limit speed and restrict creative options.
    • Shifting expectations: With telehealth and digital health expanding, audiences expect convenience, personalization, and authenticity.
    • Clinician overload: Providers are constantly receiving clinical studies, product launches, and professional updates—so irrelevant marketing is quickly dismissed.

    Strategies to Reduce Content Fatigue

    1. Prioritize Relevance Over Volume

    • Refresh and deepen buyer personas to reflect current needs.
    • Tailor content by segment—clinician, payer, patient.
    • Produce fewer, higher-impact pieces rather than high-volume, low-resonance material.

    2. Use Storytelling and Brand Archetypes

    Healthcare brands benefit from clear, human-centered narratives. Moving away from compliance-only voice toward a stronger brand personality helps content stand out.

    3. Adopt a Multi-Channel—but Intentional—Approach

    • More channels do not automatically mean more impact.
    • Ensure each channel serves a distinct strategic purpose.
    • Consider hybrid and offline approaches such as waiting-room content, direct mail, or events that complement digital campaigns.

    4. Measure Meaningfully and Adjust Quickly

    • Track opens, clicks, read time, and conversion—not just impressions.
    • A sudden drop in engagement may signal fatigue. Reduce volume, refresh themes, or test new formats.
    • Use performance insights to drive optimization, not assumptions.

    5. Experiment With Formats That Break Through

    • Use interactive tools, checklists, assessments, micro-videos, and patient stories.
    • Make content mobile-first and easy to digest.
    • Strengthen SEO and high-intent discoverability so content reaches audiences actively seeking information.

    Final Thoughts

    For healthcare marketers and sales teams, the message is clear: more content is not the answer. In a saturated landscape, increasing volume without strengthening relevance or differentiation can undermine engagement, erode trust, and stall pipeline momentum.

    The real advantage lies in creating meaningful content—fewer pieces, sharper targeting, stronger stories, and continuous refinement. When you break through the fatigue, content becomes a powerful driver of education, connection, and conversion.

    Connexio Health

    November 18, 2025
    Connexio Health, Data and Technology, Marketing
  • Connexio Health and Alpha Sophia Announce Strategic Partnership to Bridge HCP Insights and Activation 

    Connexio Health and Alpha Sophia Announce Strategic Partnership to Bridge HCP Insights and Activation 

    [October 2025] – Connexio Health and Alpha Sophia today announced a strategic partnership designed to transform how healthcare manufacturers identify, engage, and activate healthcare professionals (HCPs). 

    By combining Alpha Sophia’s robust mapping, analytics, and targeting framework with Connexio Health’s downstream marketing and education capabilities, the collaboration delivers a seamless, end-to-end HCP engagement solution—from insight to activation. 

    “Together, we’re closing the gap between intelligence and action,” said a Connexio Health spokesperson. “Our shared approach enables clients to translate deep audience insights into meaningful engagement that drives measurable results.” 

    Alpha Sophia’s platform integrates more than 100 data sources to map the entire U.S. healthcare landscape, providing precise segmentation and targeting. Connexio Health complements this with fractional sales and marketing solutions that connect manufacturers and healthcare professionals to accelerate growth and expand reach. 

    This partnership creates a full-funnel engagement stack—empowering organizations to move from insight to impact with confidence. 

    Kathryn Kellam

    October 22, 2025
    Connexio Health, News
    Data, DataConnex, News, Partnership
  • 3 Jobs Every Pharma & Med Tech Leader Must Nail Before 2026

    3 Jobs Every Pharma & Med Tech Leader Must Nail Before 2026

    For pharma and med tech leaders, 2026 isn’t a distant horizon — it’s around the corner. Planning cycles are tightening, budgets are being finalized, and commercial teams are already laying the groundwork for next year’s performance.

    But readiness isn’t about checking boxes or building bigger dashboards. It’s about ensuring the right work is done now — so you don’t spend Q1 catching up while competitors move ahead.

    Here are the three jobs that matter most before January.



    1. Align Field Resources to Growth Priorities

    Field teams are the engine of commercial success — but even the strongest team can’t deliver if coverage doesn’t match opportunity.

    Many organizations enter Q1 with territories misaligned, leaving whitespace untouched and key accounts underserved. The result? Missed engagement, slower adoption, and room for competitors to gain traction.

    What to do now:

    • Reassess coverage maps against 2026 growth targets.
    • Use data-driven segmentation to identify whitespace and high-potential accounts.
    • Build flexibility into your model — through hybrid coverage or field augmentation — to maintain reach without increasing cost.

    The brands that win in 2026 will be those that treat field coverage not as a fixed structure, but as a strategic lever for growth.

    📘 Explore more:

    Winning the Healthcare Market: A Strategic Guide to Sales & Marketing ReadinessDownload


    2. Turn Data Into Actionable Insight

    Pharma and med tech teams have never had more data — and yet many still struggle to turn that data into meaningful action.

    CRM metrics, claims feeds, prescribing trends, utilization data — all essential, but often fragmented. The job now is to transform this volume into clarity.

    What to do now:

    • Connect disparate data sources to build a unified commercial view.
    • Identify leading indicators that predict performance, not just describe it.
    • Focus analytics on “what to do next,” not “what already happened.”

    When data is simplified into clear next steps, field teams execute faster, marketers target smarter, and leadership makes decisions with confidence.

    📄 Explore more:

    Healthcare Sales Forecasting: A Practical Guide to Setting Clear Goals and Metrics for Program PerformanceDownload


    3. Build Engagement Strategies That Earn Trust

    HCP engagement expectations are evolving rapidly. Physicians don’t want more touchpoints — they want meaningful ones.

    The leaders who succeed in 2026 will integrate personal, digital, and educational interactions into a single, cohesive experience that builds credibility and drives behavior change.

    What to do now:

    • Audit your engagement mix — are digital and in-person efforts working together or in silos?
    • Focus content and cadence on HCP needs, not internal metrics.
    • Measure consistency and value, not just reach.

    Consistency creates trust — and trust drives lasting commercial success.

    🎧 Listen to learn more



    Final Thought

    The 2026 countdown isn’t about more activity — it’s about smarter execution.

    Align your field to your future, turn data into direction, and engage in ways that build trust. Do these three jobs before Q1, and you’ll enter 2026 not just ready — but ahead.

    Kathryn Kellam

    October 6, 2025
    Connexio Health, Data and Technology, Marketing, Non-Personal Promotion, VSO
    Healthcare marketing, Non Personal Promotion, Sales Strategy
  • 2026 Is Closer Than You Think: Why Now Is the Time to Start Planning

    2026 Is Closer Than You Think: Why Now Is the Time to Start Planning

    For commercial teams in healthcare, July isn’t just the heart of summer—it’s the unofficial start of planning season.

    Sure, the calendars still say 2025. However, smart healthcare manufacturers recognize that by the time Q4 arrives, the pressure is on, calendars are full, and strategy shifts from building momentum to managing urgency. That’s why now is the time to start the conversation around 2026.

    Why Early Planning Matters in Healthcare

    The healthcare landscape continues to evolve at a breakneck pace—from tightening access and rising commercialization costs to shifting provider expectations and new specialty product launches. Waiting until Q4 to develop your 2026 strategy risks missing critical opportunities to:

    • Identify whitespace and high-potential HCPs
    • Reevaluate segmentation and targeting models
    • Align budget assumptions with updated market dynamics
    • Prepare your team for a new wave of non-personal engagement tactics

    Early strategy work creates breathing room for creativity, alignment, and data-driven decision making. It’s not about moving faster—it’s about moving smarter.

    How Connexio Supports Strategy That Scales

    At Connexio, we work with healthcare manufacturers across the planning lifecycle to bring clarity, confidence, and structure to the process. Whether you’re refining your go-to-market approach, recalibrating territory models, or rethinking brand engagement in a digital-first world, we help you:

    • Turn raw data into insight through our Data Connex engine
    • Identify missed opportunities via Whitespace Connex
    • Optimize omnichannel outreach with Marketing Connex
    • Build repeatable frameworks that grow with your brand

    Our team doesn’t just help you plan—we help you win.

    Three Questions to Ask Now


    As you look toward 2026, consider these starting points for internal alignment:

    • What would it look like to go into Q4 already aligned and action-ready?
    • When does our team traditionally start strategy conversations, and is that working for us?
    • Are we still making planning decisions based on outdated market assumptions?

    Let’s Start the Conversation


    Whether you’re building a brand plan, reshaping field strategy, or just trying to get ahead of the Q4 crunch, Connexio is here to help you turn today’s planning into tomorrow’s performance.

    📅 Let’s talk 2026 readiness

    Kathryn Kellam

    July 10, 2025
    Connexio Health, Marketing
1 2 3
Next Page
  • 607-545-4010
  • info@connexiohealth.com
  • FAQs
  • Privacy Policy
  • Terms & Conditions
  • Facebook
  • https://twitter.com/ConnexioHealth
  • Instagram
  • YouTube
  • LinkedIn